News

Vilazodone is a novel dual-acting modulator of serotonin neurotransmission in development for the treatment of major depressive disorder with the potential for follow-on indications including generalised anxiety disorder

Utilising CTMS as a centralised repository for all investigators, clinical trial sponsors can collect and track all relevant information about their investigators, from personal profiles to disease specialties,

Reportedly, a mean Progression Free Survival (PFS) of 11.7 months was observed among subjects achieving an OR. In the PV-10 Phase 2 trial, a complete response (CR) of

Mycofenolatmofetil Actavis (mycophenolate mofetil) is the generic equivalent of Roche’s Cellcept, and is used with other medicines to lower the body’s immunity after heart, kidney or liver transplant.

The original contract between Nordion (formerly MDS) and Capgemini was effective June 2006, and this current contract extension calls for Capgemini to continue to provide information technology (IT)

Additionally, combined data from three other Phase III studies showed that RA patients who received Actemra had sustained improvements in signs and symptoms over nearly two years. Across

Lodotra is a proprietary programmed-release formulation of low-dose prednisone and has received regulatory approval in Europe for reduction in morning stiffness associated with rheumatoid arthritis (RA). Merck Serono

Kombiglyze XR is a once-a-day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering glycaemic control across glycosylated haemoglobin levels (HbA1c), fasting plasma glucose (FPG) and

Headquartered in Pleasanton, CA, IntegenX is a privately held company that designs, manufactures and markets automated DNA- and RNA-based sample preparation systems for life sciences, applied sciences and